Lv1
20 积分 2024-09-09 加入
Serum Anti‐Drug Antibodies in Psoriasis Patients Undergoing Biologic Therapy in Real‐World Clinical Practice: A Single‐Center Retrospective Study
10个月前
已完结
Long-term Clinical Efficacy, Safety, and Drug Survival of Ixekizumab for Patients with Psoriasis in a Real-life Setting
10个月前
已关闭
Treatment of Psoriasis with II-17 Inhibitors: Comparison of Long-Term Effectiveness and Drug Survival of Secukinumab vs Ixekizumab in Real-World Practice
10个月前
已完结
Long-term Clinical Efficacy, Safety, and Drug Survival of Ixekizumab for Patients with Psoriasis in a Real-life Setting
10个月前
已关闭
Psoriasis
1年前
已完结
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis
1年前
已完结
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety
1年前
已完结
Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation
1年前
已完结
Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients
1年前
已完结
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities
1年前
已完结
皖公网安备34019202002308
